Free Trial

Synopsys, Inc. $SNPS Shares Sold by PFG Advisors

Synopsys logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • PFG Advisors trimmed its stake in Synopsys by 47.6% in Q4, selling 8,226 shares and ending the quarter with 9,053 shares worth about $4.25 million.
  • Meanwhile, several large institutions — including Vanguard, State Street, Victory Capital and Capital Research — substantially increased positions in Q3, leaving institutional investors with about 85.47% ownership of the stock.
  • Synopsys beat Q4 estimates with EPS of $3.77 (vs. $3.56 est.) and revenue of $2.41B (vs. $2.39B), reported 65.6% YoY revenue growth, and set FY2026 EPS guidance of 14.380–14.460, while analysts' consensus rating is a Hold with a $531 target.
  • MarketBeat previews the top five stocks to own by May 1st.

PFG Advisors trimmed its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 47.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,053 shares of the semiconductor company's stock after selling 8,226 shares during the quarter. PFG Advisors' holdings in Synopsys were worth $4,252,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Synopsys by 20.7% in the third quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company's stock worth $8,970,415,000 after acquiring an additional 3,120,401 shares during the last quarter. State Street Corp grew its position in shares of Synopsys by 20.6% in the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company's stock valued at $4,322,273,000 after purchasing an additional 1,493,912 shares during the period. Victory Capital Management Inc. grew its position in shares of Synopsys by 238.8% in the third quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company's stock valued at $1,393,506,000 after purchasing an additional 1,990,608 shares during the period. Capital Research Global Investors grew its position in shares of Synopsys by 226.6% in the third quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company's stock valued at $1,245,533,000 after purchasing an additional 1,751,432 shares during the period. Finally, Van ECK Associates Corp grew its position in shares of Synopsys by 15.3% in the third quarter. Van ECK Associates Corp now owns 2,216,908 shares of the semiconductor company's stock valued at $1,093,800,000 after purchasing an additional 293,784 shares during the period. 85.47% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

SNPS has been the subject of a number of research reports. Needham & Company LLC reissued a "buy" rating on shares of Synopsys in a research report on Thursday, February 26th. Wells Fargo & Company lowered their price target on Synopsys from $500.00 to $450.00 and set an "equal weight" rating for the company in a research report on Thursday, February 26th. HSBC downgraded Synopsys from a "buy" rating to a "hold" rating and set a $455.00 price target for the company. in a research report on Friday, February 20th. Piper Sandler lowered their price target on Synopsys from $520.00 to $430.00 and set a "neutral" rating for the company in a research report on Thursday, February 26th. Finally, Morgan Stanley reissued an "equal weight" rating and issued a $480.00 target price (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. Eight analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Synopsys has a consensus rating of "Hold" and a consensus target price of $531.00.

View Our Latest Report on SNPS

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $460.95 on Tuesday. Synopsys, Inc. has a 1-year low of $376.18 and a 1-year high of $651.73. The business has a 50-day moving average of $422.69 and a 200-day moving average of $444.87. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26. The company has a market capitalization of $88.30 billion, a price-to-earnings ratio of 71.58, a PEG ratio of 3.67 and a beta of 1.15.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, topping the consensus estimate of $3.56 by $0.21. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The company had revenue of $2.41 billion during the quarter, compared to the consensus estimate of $2.39 billion. During the same quarter in the prior year, the business earned $3.03 earnings per share. The company's revenue was up 65.6% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, equities analysts anticipate that Synopsys, Inc. will post 10.3 EPS for the current fiscal year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Articles

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines